In vivo cancer targeting and imaging-guided surgery with near infrared-emitting quantum dot bioconjugates

Theranostics

Volumn 2, Issue 8, 2012, Pages 769-776

  Li, Yan ^a   Li, Zhe ^b   Wang, Xiaohui ^b   Liu, Fengjun ^b   Cheng, Yingsheng ^b   Zhang, Bingbo ^b   Shi, Donglu ^b,c  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b TONGJI UNIVERSITY   (China)

^c University of Cincinnati   (United States)

Author keywords

Cancer treatment; Cancer targeted imaging; Imaging guided surgery; NIR quantum dots; RGD

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CADMIUM CHLORIDE; QUANTUM DOT; TELLURIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG TARGETING; FEMALE; FLUORESCENCE; IMAGING GUIDED SURGERY; IN VIVO STUDY; INFRARED RADIATION; MOUSE; NONHUMAN; PHOTOLUMINESCENCE; QUANTUM YIELD; SURGICAL TECHNIQUE; TUMOR VOLUME;

EID: 84866050723     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.4690     Document Type: Article

References (55)

1. Tagaya N, Yamazaki R, Nakagawa A, Abe A, Hamada K, Kubota K, et al. Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008; 195: 850-3.
2. Jiang S, Gnanasammandhan MK, Zhang Y. Optical imaging-guided cancer therapy with fluorescent nanoparticles. J R Soc Interface. 2010; 7: 3-18.
3. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol. 1996; 22: 17-22.
4. Schiller DE, Le LW, Cho BCJ, Youngson BJ, McCready DR. Factors associated with negative margins of lumpectomy specimen: Potential use in selecting patients for intraoperative radiotherapy. Ann Surg Oncol. 2008; 15: 833-42.
5. Hadjipavlou AG, Kambin P, Lander PH, Crow WN, Simmons JW. Imaging guided minimally invasive surgery for low back pain sciatica and spinal infection. J Interv Radiol. 1999; 14: 1-22.
6. van Dam GM, Themelis G, Crane LMA, Harlaar NJ, Pleijhuis RG, Kelder W, et al. Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med. 2011; 17: 1315-U202.
7. Zheng XH, Xing D, Zhou FF, Wu BY, Chen WR. Indocyanine Green-Containing Nanostructure as Near Infrared Dual-Functional Targeting Probes for Optical Imaging and Photothermal Therapy. Mol Pharm. 2011; 8: 447-56.
8. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. Faseb J. 2005; 19: 311-30.
9. Kumar B, Yadav PR, Goel HC, Rizvi MMA. Recent Developments in Cancer Therapy by the Use of Nanotechnology. Dig J Nanomater Bios. 2009; 4: 51-7.
10. Yezhelyev MV, Gao X, Xing Y, Al-Hajj A, Nie SM, O'Regan RM. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol. 2006; 7: 657-67.
11. Kievit FM, Zhang MQ. Surface Engineering of Iron Oxide Nanoparticies for Targeted Cancer Therapy. Acc Chem Res. 2011; 44: 853-62.
12. Invernici G, Cristini S, Alessandri G, Navone SE, Canzi L, Tavian D, et al. Nanotechnology Advances in Brain Tumors: The State of the Art. Recent Pat Anticancer Drug Discov. 2011; 6: 58-69.
13. Groneberg DA, Giersig M, Welte T, Pison U. Nanoparticle-based diagnosis and therapy. Curr Drug Targets. 2006; 7: 643-8.
14. Gao JH, Chen K, Miao Z, Ren G, Chen XY, Gambhir SS, et al. Affibody-based nanoprobes for HER2-expressing cell and tumor imaging. Biomaterials. 2011; 32: 2141-8.
15. Yang Q, Gong X, Song T, Yang J, Zhu S, Li Y, et al. Quantum dot-based immunochromatography test strip for rapid, quantitative and sensitive detection of alpha fetoprotein. Biosens Bioelectron. 2011; 30: 145-50.
16. Tanaka E, Choi HS, Fujii H, Bawendi MG, Frangioni JV. Image-guided oncologic surgery using invisible light: Completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol. 2006; 13: 1671-81.
17. Liang GX, Gu MM, Zhang JR, Zhu JJ. Preparation and bioapplication of high-quality, water-soluble, biocompatible, and near-infrared-emitting CdSeTe alloyed quantum dots. Nanotechnology. 2009; 20: 415103.
18. Ruan G, Agrawal A, Marcus AI, Nie S. Imaging and tracking of tat peptide-conjugated quantum dots in living cells: new insights into nanoparticle uptake, intracellular transport, and vesicle shedding. J Am Chem Soc. 2007; 129: 14759-66.
19. Peng XG, Manna L, Yang WD, Wickham J, Scher E, Kadavanich A, et al. Shape control of CdSe nanocrystals. Nature. 2000; 404: 59-61.
20. Kim GB, Kim YP. Analysis of Protease Activity Using Quantum Dots and Resonance Energy Transfer. Theranostics. 2012; 2: 127-38.
21. Yezhelyev MV, Qi LF, O'Regan RM, Nie S, Gao XH. Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc. 2008; 130: 9006-12.
22. Xing Y, Chaudry Q, Shen C, Kong KY, Zhau HE, WChung L, et al. Bioconjugated quantum dots for multiplexed and quantitative immunohistochemistry. Nat Protoc. 2007; 2: 1152-65.
23. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labelling and sensing. Nat Mater. 2005; 4: 435-46.
24. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol. 2003; 21: 47-51.
25. Lim YT, Kim S, Nakayama A, Stott NE, Bawendi MG, Frangioni JV. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging. 2003; 2: 50-64.
26. Zou L, Gu ZY, Zhang N, Zhang YL, Fang Z, Zhu WH, et al. Ultrafast synthesis of highly luminescent green- to near infrared-emitting CdTe nanocrystals in aqueous phase. J Mater Chem. 2008; 18: 2807-15.
27. Hu DH, Zhang PF, Gong P, Lian SH, Lu YY, Gao DY, et al. A fast synthesis of near-infrared emitting CdTe/CdSe quantum dots with small hydrodynamic diameter for in vivo imaging probes. Nanoscale. 2011; 3: 4724-32.
28. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJ, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials. 2008; 29: 1912-9.
29. Schipper ML, Iyer G, Koh AL, Cheng Z, Ebenstein Y, Aharoni A, et al. Particle Size, Surface Coating, and PEGylation Influence the Biodistribution of Quantum Dots in Living Mice. Small. 2009; 5: 126-34.
30. Sharifi S, Behzadi S, Laurent S, Laird Forrest M, Stroeve P, Mahmoudi M. Toxicity of nanomaterials. Chem Soc Rev. 2012; 41: 2323-43.
31. Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today. 2008; 3: 40-7.
32. Gao JH, Chen K, Xie RG, Xie J, Lee S, Cheng Z, et al. Ultrasmall Near-Infrared Non-cadmium Quantum Dots for in vivo Tumor Imaging. Small. 2010; 6: 256-61.
33. Liu Q, Sun Y, Yang TS, Feng W, Li CG, Li FY. Sub-10 nm Hexagonal Lanthanide-Doped NaLuF(4) Upconversion Nanocrystals for Sensitive Bioimaging in Vivo. J Am Chem Soc. 2011; 133: 17122-5.
34. Longmire MR, Ogawa M, Choyke PL, Kobayashi H. Biologically optimized nanosized molecules and particles: more than just size. Bioconjug Chem. 2011; 22: 993-1000.
35. Hawrysz DJ, Sevick-Muraca EM. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia. 2000; 2: 388-417.
36. Gioux S, Choi HS, Frangioni JV. Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation. Mol Imaging. 2010; 9: 237-55.
37. Park J, Dvoracek C, Lee KH, Galloway JF, Bhang HEC, Pomper MG, et al. CuInSe/ZnS Core/Shell NIR Quantum Dots for Biomedical Imaging. Small. 2011; 7: 3148-52.
38. Kim JS, Cho KJ, Tran TH, Nurunnabi M, Moon TH, Hong SM, et al. In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres. J Colloid Interf Sci. 2011; 353: 363-71.
39. Gao J, Chen X, Cheng Z. Near-infrared quantum dots as optical probes for tumor imaging. Curr Top Med Chem. 2010; 10: 1147-57.
40. Peters TM. Image-guided surgery: from X-rays to virtual reality. Comput Methods Biomech Biomed Engin. 2000; 4: 27-57.
41. Hattori A, Suzuki N, Otori N, Iimura J, Moriyama H. Development of a real-time image-guided surgery system for stereo-endoscopic sinus surgery. Stud Health Technol Inform. 2009; 142: 112-6.
42. Moon WK, Lin Y, O'Loughlin T, Tang Y, Kim DE, Weissleder R, et al. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjug Chem. 2003; 14: 539-45.
43. Chen X, Conti PS, Moats RA. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts. Cancer Res. 2004; 64: 8009-14.
44. Pons T, Pic E, Lequeux N, Cassette E, Bezdetnaya L, Guillemin F, et al. Cadmium-Free CuInS(2)/ZnS Quantum Dots for Sentinel Lymph Node Imaging with Reduced Toxicity. Acs Nano. 2010; 4: 2531-8.
45. Kobayashi H, Hama Y, Koyama Y, Barrett T, Regino CAS, Urano Y, et al. Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. Nano Lett. 2007; 7: 1711-6.
46. Tamilvanan S. Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. Int J Pharmaceut. 2009; 381: 62-76.
47. Danhier F, Feron O, Preat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010; 148: 135-46.
48. Huynh NT, Roger E, Lautram N, Benoit JP, Passirani C. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. Nanomedicine-Uk. 2010; 5: 1415-33.
49. Cai WB, Shin DW, Chen K, Gheysens O, Cao QZ, Wang SX, et al. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett. 2006; 6: 669-76.
50. Wong MLH, Prawira A, Kaye AH, Hovens CM. Tumour angiogenesis: Its mechanism and therapeutic implications in malignant gliomas. J Clin Neurosci. 2009; 16: 1119-30.
51. Xiong JP, Stehle T, Zhang R, Joachimiak A, Frech M, Goodman SL, et al. Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand. Science. 2002; 296: 151-5.
52. Ye YP, Chen XY. Integrin Targeting for Tumor Optical Imaging. Theranostics. 2011; 1: 102-26.
53. Millard M, Odde S, Neamati N. Integrin Targeted Therapeutics. Theranostics. 2011; 1: 154-88.
54. Yezhelyev MV, Al-Hajj A, Morris C, Marcus AI, Liu T, Lewis M, et al. In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv Mater. 2007; 19: 3146-51.
55. Peng CW, Li Y. Application of Quantum Dots-Based Biotechnology in Cancer Diagnosis: Current Status and Future Perspectives. J Nanomater. 2010;:676-839.